Radiation Oncology Professor at Harvard Medical School, Emeritus
Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy? Ann Surg Oncol. 2002 Mar; 9(2):117-9.
Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy?
Kaufmann M, Morrow M, von Minckwitz G, Harris JR
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer. 2010 Mar 01; 116(5):1184-91.
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel.
Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS
The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg. 2006 Jul; 192(1):58-62.
The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
Arvold ND, Oh KS, Niemierko A, Taghian AG, Lin NU, Abi-Raad RF, Sreedhara M, Harris JR, Alexander BM
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Res Treat. 2012 Nov; 136(1):153-60.
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
International journal of radiation oncology, biology, physics
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. Int J Radiat Oncol Biol Phys. 2005 Jul 01; 62(3):623-5.
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway.
Balboni TA, Chen MH, Harris JR, Recht A, Stevenson MA, D'Amico AV
Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):183-6.
Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience.
Post-mastectomy radiation therapy: translating local benefits into improved survival. Breast. 2007 Dec; 16 Suppl 2:S78-83.
Post-mastectomy radiation therapy: translating local benefits into improved survival.
Wo JY, Taghian AG, Nguyen PL, Raad RA, Sreedhara M, Bellon JR, Wong JS, Gadd MA, Smith BL, Harris JR
The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):188-96.
The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
Abbreviated course of radiotherapy (RT) for breast cancer. Breast. 2011 Oct; 20 Suppl 3:S116-27.
Abbreviated course of radiotherapy (RT) for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Evolution of breast-conserving therapy for localized breast cancer. J Clin Oncol. 2008 Mar 20; 26(9):1395-6.
Evolution of breast-conserving therapy for localized breast cancer.
Hattangadi JA, Taback N, Neville BA, Harris JR, Punglia RS
Journal of the National Cancer Institute
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst. 2012 Jan 04; 104(1):29-41.
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance.
Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR
Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol. 2008 Oct 20; 26(30):4981-9.
Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review.
Irradiation in early-stage breast cancer: conventional whole-breast, accelerated partial-breast, and accelerated whole-breast strategies compared. Oncology (Williston Park). 2012 Sep; 26(9):820-30.
Irradiation in early-stage breast cancer: conventional whole-breast, accelerated partial-breast, and accelerated whole-breast strategies compared.
Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE
Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Ann Surg Oncol. 2013 Mar; 20(3):811-8.
Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
William Rosenberg Professor of Medicine, Emeritus
Associate Professor of Radiation Oncology
Anne E. Dyson Professor in Women's Cancers, Emeritus
Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61.
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Hypofractionation in the era of modulated radiotherapy (RT). Breast. 2013 Aug; 22 Suppl 2:S129-36.
Hypofractionation in the era of modulated radiotherapy (RT).
Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol. 2012 May; 19(5):1508-16.
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.
Smith GL, Xu Y, Buchholz TA, Smith BD, Giordano SH, Haffty BG, Vicini FA, White JR, Arthur DW, Harris JR, Shih YC
Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011 Jan 10; 29(2):157-65.
Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care.
Haffty BG, Hunt KK, Harris JR, Buchholz TA
Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011 Dec 01; 29(34):4479-81.
Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.
Wong JS, Chen YH, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Smith BL, Troyan SL, Harris JR
Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat. 2014 Jan; 143(2):343-50.
Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):553-64.
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014 Mar; 21(3):704-16.
Milestones in the use of combined-modality radiation therapy and chemotherapy. J Clin Oncol. 2014 Apr 20; 32(12):1173-9.
Milestones in the use of combined-modality radiation therapy and chemotherapy.
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014 May 10; 32(14):1507-15.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Fifty years of progress in radiation therapy for breast cancer. Am Soc Clin Oncol Educ Book. 2014; 21-5.
Fifty years of progress in radiation therapy for breast cancer.
Montazeri K, Unitt C, Foody JM, Harris JR, Partridge AH, Moslehi J
ABCDE steps to prevent heart disease in breast cancer survivors. Circulation. 2014 Oct 28; 130(18):e157-9.
ABCDE steps to prevent heart disease in breast cancer survivors.
Braunstein LZ, Brock JE, Chen YH, Truong L, Russo AL, Arvold ND, Harris JR
Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin. Breast Cancer Res Treat. 2015 Jan; 149(2):555-64.
Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
Journal of the National Cancer Institute. Monographs
Radiotherapy Issues After Neoadjuvant Chemotherapy. J Natl Cancer Inst Monogr. 2015 May; 2015(51):87-9.
Radiotherapy Issues After Neoadjuvant Chemotherapy.
Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes. JAMA Oncol. 2016 Aug 01; 2(8):991-2.
Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.
Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):287-295.
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. J Clin Oncol. 2016 11 20; 34(33):4040-4046.
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol. 2016 11; 23(12):3801-3810.
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.
Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer-Reply. JAMA Oncol. 2017 01 01; 3(1):127.
Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer-Reply.
Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, Wong JS, Punglia RS, MacDonald SM, Harris JR
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017 01; 161(1):173-179.
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, White J, Harris JR
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):73-79.
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.
Mihalcik SA, Rawal B, Braunstein LZ, Capuco A, Wong JS, Punglia RS, Bellon JR, Harris JR
The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy. Ann Surg Oncol. 2017 Jul; 24(7):1868-1873.
The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy.
Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL
Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006 Mar 01; 24(7):1031-6.
Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, Julian TB, Marks LB, Todor DA, Vicini FA, Whelan TJ, White J, Wo JY, Harris JR
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):987-1001.
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).
Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht A
A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004 Apr 01; 100(7):1358-64.
A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002 Nov 01; 95(9):1988-99.
Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies.
Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP
Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005 Mar 12-18; 365(9463):963-4.
Offering participants results of a clinical trial: sharing results of a negative study.
Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP
Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002 Sep-Oct; 52(5):277-300.
Standard for breast conservation therapy in the management of invasive breast carcinoma.
What extent of radiation therapy is standard? Breast. 2005 Dec; 14(6):532-40.
What extent of radiation therapy is standard?
Clinical dilemma of ductal carcinoma in situ. J Clin Oncol. 2009 Nov 10; 27(32):5303-5.
Clinical dilemma of ductal carcinoma in situ.
Chen MH, Cash EP, Danias PG, Kissinger KV, Bornstein BA, Rhodes LM, Gelman R, Harris JR, Manning WJ
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson. 2002; 4(2):265-71.
Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer.
Radiation therapy for invasive breast cancer: not just for local control. J Clin Oncol. 2005 Mar 10; 23(8):1607-8.
Radiation therapy for invasive breast cancer: not just for local control.
Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys. 2006 Feb 01; 64(2):496-504.
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
Lim M, Bellon JR, Gelman R, Silver B, Recht A, Schnitt SJ, Harris JR
A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1149-54.
A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.
Punglia RS, Morrow M, Winer EP, Harris JR
Local therapy and survival in breast cancer. N Engl J Med. 2007 Jun 07; 356(23):2399-405.
Local therapy and survival in breast cancer.
Landis DM, Luo W, Song J, Bellon JR, Punglia RS, Wong JS, Killoran JH, Gelman R, Harris JR
Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1299-308.
Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity.
Wong JS, Taghian AG, Bellon JR, Keshaviah A, Smith BL, Winer EP, Silver B, Harris JR
Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):866-70.
Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial.
Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast. J Surg Oncol. 2007 Jun 15; 95(8):610-3.
Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
Journal of the American College of Surgeons
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009 Aug; 209(2):269-77.
Winer EP, Harris JR, Smith BL, D'Alessandro HA, Brachtel EF
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer. N Engl J Med. 2007 Oct 18; 357(16):1640-8.
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol. 2008 Feb 10; 26(5):791-7.
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Effective local therapy and long-term survival in breast cancer. Oncology (Williston Park). 2009 Jul; 23(8):669-75.
Effective local therapy and long-term survival in breast cancer.
Smith BD, Pan IW, Shih YC, Smith GL, Harris JR, Punglia R, Pierce LJ, Jagsi R, Hayman JA, Giordano SH, Buchholz TA
Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst. 2011 May 18; 103(10):798-809.
Adoption of intensity-modulated radiation therapy for breast cancer in the United States.
Wallner PE, Ang KK, Zietman AL, Harris JR, Ibbott GS, Mahoney MC, Mezwa DG, Wilson LD, Becker GJ
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performance. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):29-34.
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performance.
Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR
Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):406-14.
Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Molecular predictors of local tumor control in early-stage breast cancer. Semin Radiat Oncol. 2011 Jan; 21(1):35-42.
Molecular predictors of local tumor control in early-stage breast cancer.
Barkley C, Burstein H, Smith B, Bellon J, Wong J, Gadd M, Taghian A, Winer E, Iglehart JD, Harris J, Golshan M
Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates? Breast J. 2012 Jan-Feb; 18(1):23-7.
Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates?
Halasz LM, Sreedhara M, Chen YH, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE
Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):e581-6.
Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht A
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20; 23(9):1934-40.
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006 Jul 01; 65(3):640-5.
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008 May 10; 26(14):2373-8.
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Hattangadi-Gluth JA, Wo JY, Nguyen PL, Abi Raad RF, Sreedhara M, Niemierko A, Freer PE, Georgian-Smith D, Bellon JR, Wong JS, Smith BL, Harris JR, Taghian AG
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1185-91.
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.
Integrating surgery and radiotherapy to reduce toxicity while maintaining local control for breast cancer: a fine balance. Ann Surg Oncol. 2002 Jul; 9(6):526-8.
Integrating surgery and radiotherapy to reduce toxicity while maintaining local control for breast cancer: a fine balance.
Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011 Oct 10; 29(29):3885-91.
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Surgical margins in lumpectomy for breast cancer--bigger is not better. N Engl J Med. 2012 Jul 05; 367(1):79-82.
Surgical margins in lumpectomy for breast cancer--bigger is not better.
Wong JS, Ho AY, Kaelin CM, Bishop KL, Silver B, Gelman R, Harris JR, Hergrueter CA
Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy. Breast J. 2008 Jan-Feb; 14(1):49-54.
Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy.
More mastectomies: is this what patients really want? J Clin Oncol. 2009 Sep 01; 27(25):4038-40.
More mastectomies: is this what patients really want?
Innovations in radiation therapy (RT) for breast cancer. Breast. 2009 Oct; 18 Suppl 3:S103-11.
Innovations in radiation therapy (RT) for breast cancer.
Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):152-9.
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence? J Clin Oncol. 2005 Jan 01; 23(1):5-7.
Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence?
Galper S, Blood E, Gelman R, Abner A, Recht A, Kohli A, Wong JS, Smith D, Bellon J, Connolly J, Schnitt S, Winer E, Silver B, Harris JR
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):348-57.
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.